Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or ...

The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...

Capecitabine (Xeloda ™; Roche, Nutley, NJ) is an oral prodrug of 5-fluorourarcil (5-FU) that undergoes a three-step enzymatic activation process to be converted to the active drug. This three ...

The physician's choice of therapy included Novartis' EGFR/HER2 inhibitor Tykerb (lapatinib) plus Roche's chemotherapeutic drug Xeloda (capecitabine), or Roche's HER2 therapy Herceptin (trastuzumab ...

Phase II Study of Ipilimumab, Nivolumab, and Panitumumab in Patients With KRAS/NRAS/BRAF Wild-Type Microsatellite Stable Metastatic Colorectal Cancer Females with MBC and any previous lines of therapy ...

其中2宗事件涉及圣保禄医院，包括一名40岁男病人被注射错误剂量的鸦片类止痛药物，以及一名36岁男病人服用错误剂量的口服化疗药物。馀下1宗事件则涉及养和医院，涉及一名33岁、曾有过敏史的女病人错误获发含扑热息痛的口服药物。

A Nigerian scientist, Ayomide Adebesin, has said she has made a discovery in cancer treatment by exploring the therapeutic potential of natural plant compounds.In a statement made available to PUNCH ...

For example, in March 2024, the FDA 2 made labelling changes to injectable 5-fluorouracil (5-FU, capecitabine (Xeloda)) warning clinicians that treatment comes with a strong risk of severe side ...